Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 3/20 | 0.34 |
| ▸ | HDAC3 known ✓ | O15379 | 1/20 | 0.32 |
| ▸ | HDAC4 known ✓ | P56524 | 1/20 | 0.32 |
| ▸ | HDAC2 known ✓ | Q92769 | 1/20 | 0.32 |
| ▸ | HDAC8 known ✓ | Q9BY41 | 1/20 | 0.32 |
| ▸ | APAF1 | O14727 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | SNCA | P37840 | 4/20 | 0.37 |
| ▸ | NOX1 | Q9Y5S8 | 6/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28617143 | 1.00 | APAF1 (0.46) | APAF1MAPTSNCANOX1MAPK1 | |
| Hydrochloric Acid SCHEMBL20676747 | 0.94 | APAF1 (0.42) | APAF1MAPTSNCANOX1MAPK1 | |
| SCHEMBL3931877 | 0.93 | APAF1 (0.43) | APAF1MAPTSNCANOX1MAPK1 | |
| Hydromethylthionine SCHEMBL29625238 | 0.84 | SNCA (0.48) | MAPTSNCANOX1MAPK1GAA | |
| Hydromethylthionine SCHEMBL31159644 | 0.84 | SNCA (0.48) | MAPTSNCANOX1MAPK1GAA | |
| Hydromethylthionine SCHEMBL1577040 | 0.84 | SNCA (0.48) | MAPTSNCANOX1MAPK1GAA | |
| Hydromethylthionine SCHEMBL31481566 | 0.83 | SNCA (0.47) | MAPTSNCANOX1MAPK1GAA | |
| Hydromethylthionine SCHEMBL12592446 | 0.83 | SNCA (0.50) | MAPTSNCANOX1MAPK1GAA | |
| Hydromethylthionine SCHEMBL29356148 | 0.83 | SNCA (0.50) | MAPTSNCANOX1MAPK1GAA | |
| Hydromethylthionine SCHEMBL109756 | 0.83 | SNCA (0.50) | MAPTSNCANOX1MAPK1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250216301-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II) | ESSENLIX CORPORATION (US) | 2025-07-03 | — | — | US | disclosed |
| US-12169167-B2 | Devices and methods for tissue and cell staining (II) | ESSENLIX CORPORATION (US) | 2024-12-17 | — | — | US | disclosed |
| US-20240125705-A1 | ENHANCED, RAPID, HOMOGENEOUS, CELL STAINING AND ASSAY | ESSENLIX CORPORATION (US) | 2024-04-18 | — | — | US | disclosed |
| US-11906432-B2 | Enhanced, rapid, homogeneous, cell staining and assay | ESSENLIX CORPORATION (US) | 2024-02-20 | — | — | US | disclosed |
| US-20220042884-A1 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II) | ESSENLIX CORPORATION (US) | 2022-02-10 | — | — | US | disclosed |
| US-20210247317-A1 | ENHANCED, RAPID, HOMOGENEOUS, CELL STAINING AND ASSAY | ESSENLIX CORPORATION (US) | 2021-08-12 | — | — | US | disclosed |
| EP-3841368-A1 | ENHANCED, RAPID, HOMOGENEOUS, CELL STAINING AND ASSAY | Essenlix Corporation (US) | 2021-06-30 | — | — | EP | disclosed |
| WO-2020150751-A2 | DEVICES AND METHODS FOR TISSUE AND CELL STAINING (II) | ESSENLIX CORPORATION (US) | 2020-07-23 | — | — | WO | disclosed |
| WO-2020041781-A1 | ENHANCED, RAPID, HOMOGENEOUS, CELL STAINING AND ASSAY | ESSENLIX CORPORATION (US) | 2020-02-27 | — | — | WO | disclosed |
| EP-2267453-B1 | Method for a fully automated monoclonal antibody-based extended differential | BECKMAN COULTER INC (US) | 2016-08-17 | — | — | EP | disclosed |
| EP-1747460-A2 | METHOD FOR A FULLY AUTOMATED MONOCLONAL ANTIBODY-BASED EXTENDED DIFFERENTIAL | Beckman Coulter, Inc. (US) | 2007-01-31 | — | — | EP | disclosed |
| US-20060269970-A1 | Method for a fully automated monoclonal antibody-based extended differential | BECKMAN COULTER, INC. (US) | 2006-11-30 | — | — | US | disclosed |
| WO-2006093892-A2 | COMPOSITIONS AND METHODS OF DETECTING AN ANALYTE BY USING A NUCLEIC ACID HYBRIDIZATION SWITCH PROBE | GEN-PROBE INCORPORATED (US) | 2006-09-08 | — | — | WO | disclosed |
| US-20060194240-A1 | Compositions and methods of detecting an analyte by using a nucleic acid hybridization switch probe | GEN-PROBE INCORPORATED (US) | 2006-08-31 | — | — | US | disclosed |
| EP-1604039-A2 | DYE COMPOSITIONS WHICH PROVIDE ENHANCED DIFFERENTIAL FLUORESCENCE AND LIGHT SCATTER CHARACTERISTICS | Beckman Coulter, Inc. (US) | 2005-12-14 | — | — | EP | disclosed |
| WO-2005114191-A2 | METHOD FOR A FULLY AUTOMATED MONOCLONAL ANTIBODY-BASED EXTENDED DIFFERENTIAL | BECKMAN COULTER, INC. (US) | 2005-12-01 | — | — | WO | disclosed |
| US-20050260766-A1 | Method for a fully automated monoclonal antibody-based extended differential | BECKMAN COULTER, INC. (US) | 2005-11-24 | — | — | US | disclosed |
| US-6955872-B2 | Dye compositions which provide enhanced differential fluorescence and light scatter characteristics | COULTER INTERNATIONAL CORP. (US) | 2005-10-18 | — | — | US | disclosed |
| WO-2004085989-A2 | DYE COMPOSITIONS WHICH PROVIDE ENHANCED DIFFERENTIAL FLUORESCENCE AND LIGHT SCATTER CHARACTERISTICS | BECKMAN COULTER, INC. (US) | 2004-10-07 | — | — | WO | disclosed |
| US-20040185447-A1 | Dye compositions which provide enhanced differential fluorescence and light scatter characteristics | COULTER INTERNATIONAL CORP. | 2004-09-23 | — | — | US | disclosed |